Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:116-122
Published online before print December 1, 2005, doi: 10.1161/01.STR.0000195044.44442.e0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/1/116    most recent
01.STR.0000195044.44442.e0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhle, S.
Right arrow Articles by deVeber, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhle, S.
Right arrow Articles by deVeber, G.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Stroke
Related Collections
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Heparin
Right arrow Coumarins
Right arrow Thrombophilia
Right arrow Acute Cerebral Infarction
Right arrow Cerebral Venous Thrombosis
Right arrow Stroke in Children and the Young
Right arrowRelated Article

(Stroke. 2006;37:116.)
© 2006 American Heart Association, Inc.


Original Contributions

Urgent Clinical Challenges in Children With Ischemic Stroke

Analysis of 1065 Patients From the 1-800-NOCLOTS Pediatric Stroke Telephone Consultation Service

Stefan Kuhle, MD; Lesley Mitchell, MSc; Maureen Andrew, MD; Anthony K. Chan, MBBS; Patricia Massicotte, MD; Margaret Adams, RN Gabrielle deVeber, MD

From the Department of Pediatrics (S.K., L.M., P.M.), Thrombosis Program, Stollery Children’s Hospital, Edmonton, Alberta, Canada; Department of Pediatrics (M. Andrew, deceased), Division of Hematology, Hospital for Sick Children, Toronto Ontario, Canada; Department of Pediatrics (A.K.C.), Division of Hematology, Children’s Hospital at Chedoke McMaster, Hamilton, Ontario, Canada; and Department of Pediatrics (M. Adams, G.d.), Division of Neurology, Hospital for Sick Children, Toronto, Ontario, Canada.

Correspondence to Gabrielle deVeber, MD, Department of Pediatrics, Division of Neurology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, M5G 1X8 Canada. E-mail deveber{at}sickkids.ca

Background and Purpose— Clinical trials are lacking in pediatric stroke. As a result, physicians caring for children with stroke face significant challenges. The patient characteristics and specific nature of clinical challenges facing practicing clinicians can inform the design of and priorities for developing relevant clinical trials.

Methods— Physicians consulted the 1-800-NOCLOTS toll-free pediatric stroke telephone consultation service on children (birth to 18 years) with ischemic stroke. Pediatric neurologist or hematologists provided telephone consultation and documented caller and patient characteristics, antithrombotic treatments and callers’ questions for entry into a computerized database. Children referred from January 1, 1995 to January 1, 2004, comprised the study cohort.

Results— Stroke consults were completed on 1065 children located predominantly in the United States (76%). Children had arterial ischemic stroke (AIS; 679; 64%) or cerebral sinovenous thrombosis (CSVT; 386; 36%) and were 54% male and 16% neonates. Risk factors and antithrombotic agents (none, aspirin, warfarin, and heparins) differed by stroke type. In 60% of patients, callers had not initiated antithrombotic therapy. Callers’ questions for both stroke types usually concerned treatment selection (83%), but for AIS, questions more frequently (P<0.0001) concerned the selection and interpretation of etiological investigations.

Conclusions— Research is urgently needed in pediatric stroke to provide direction for management in "real-life" settings. Research efforts should address the unique challenges within different stroke types and include observational studies addressing investigation of the child with AIS. For AIS and CSVT, randomized controlled trials investigating the efficacy of antithrombotic treatment are urgently needed.


Key Words: infants • child • sinus thrombosis • stroke, ischemic


Related Article:

The Emerging Quandary of Childhood Stoke: Better Aim but No Magic Bullet
Heather J. Fullerton
Stroke 2006 37: 3. [Full Text] [PDF]



This article has been cited by other articles:


Home page
StrokeHome page
W. Lo, K. Zamel, K. Ponnappa, A. Allen, D. Chisolm, M. Tang, B. Kerlin, and K. O. Yeates
The Cost of Pediatric Stroke Care and Rehabilitation
Stroke, January 1, 2008; 39(1): 161 - 165.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. J. Fullerton, Y. W. Wu, S. Sidney, and S. C. Johnston
Risk of Recurrent Childhood Arterial Ischemic Stroke in a Population-Based Cohort: The Importance of Cerebrovascular Imaging
Pediatrics, March 1, 2007; 119(3): 495 - 501.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. M. Burger, K. J. Murphy, L. C. Jordan, R. J. Tamargo, and P. Gailloud
Safety of Cerebral Digital Subtraction Angiography in Children: Complication Rate Analysis in 241 Consecutive Diagnostic Angiograms
Stroke, October 1, 2006; 37(10): 2535 - 2539.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H. J. Fullerton
The Emerging Quandary of Childhood Stoke: Better Aim but No Magic Bullet
Stroke, January 1, 2006; 37(1): 3 - 3.
[Full Text] [PDF]